Lantheus Holdings (NASDAQ: LNTH) held its fourth-quarter and full-year 2024 earnings call on Feb. 26, 2025, highlighting achievements in its radiopharmaceutical portfolio and announcing strategic ...

Worldwide revenue of $391.1 million and $1.53 billion for the fourth quarter and full year 2024Free cash flow was $141.4 million and $493.1 ...

We recently published a list of 15 Best Fast Growth Stocks To Buy Right Now. In this article, we are going to take a look at ...

In the fourth quarter of 2024, the US Gross Domestic Product (GDP) expanded at an annual rate of 2.3%, slightly below market ...

LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) began 2025 with a pair of potentially ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray ...

Lantheus Stock Down 2.5 % Shares of NASDAQ:LNTH opened at $79.94 on Friday. The firm’s 50 day moving average price is $91.43 and its 200 day moving average price is $97.79. The stock has a ...

In a recent transaction, James H. Thrall, a director at Lantheus (NASDAQ:LNTH) Holdings, Inc. (NASDAQ:LNTH), sold 1,000 shares of the company's common stock. The shares were sold ...

Highlights,Stratos Wealth Partners LTD. reduced its holdings by 6.0% to 2,474 shares.,Institutional investors own 99.06% of Lantheus.,Market capitalization stands at $5.70 billion.,Institutional ...

In other Lantheus news, Director James H. Thrall sold 1,000 shares of the company’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $94.76, for ...